Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol
Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5.
Autor*in: |
Compton, Wilson M. [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2013 |
---|
Schlagwörter: |
---|
Umfang: |
4 |
---|
Übergeordnetes Werk: |
Enthalten in: Statistical analysis to identify biomarkers for safety - Clark, Matthew ELSEVIER, 2018, an international journal on biomedical and psychosocial approaches, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:132 ; year:2013 ; number:1 ; day:1 ; month:09 ; pages:387-390 ; extent:4 |
Links: |
---|
DOI / URN: |
10.1016/j.drugalcdep.2013.02.036 |
---|
Katalog-ID: |
ELV016911024 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV016911024 | ||
003 | DE-627 | ||
005 | 20230623132325.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180602s2013 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.drugalcdep.2013.02.036 |2 doi | |
028 | 5 | 2 | |a GBVA2013012000002.pica |
035 | |a (DE-627)ELV016911024 | ||
035 | |a (ELSEVIER)S0376-8716(13)00107-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 15,3 |2 ssgn | ||
084 | |a PHARM |q DE-84 |2 fid | ||
084 | |a 44.38 |2 bkl | ||
084 | |a 44.39 |2 bkl | ||
100 | 1 | |a Compton, Wilson M. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol |
264 | 1 | |c 2013 | |
300 | |a 4 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5. | ||
650 | 7 | |a Substance use disorder |2 Elsevier | |
650 | 7 | |a DSM-IV |2 Elsevier | |
650 | 7 | |a DSM-5 |2 Elsevier | |
650 | 7 | |a Kappa |2 Elsevier | |
650 | 7 | |a Concordance |2 Elsevier | |
650 | 7 | |a Diagnosis |2 Elsevier | |
700 | 1 | |a Dawson, Deborah A. |4 oth | |
700 | 1 | |a Goldstein, Risë B. |4 oth | |
700 | 1 | |a Grant, Bridget F. |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Clark, Matthew ELSEVIER |t Statistical analysis to identify biomarkers for safety |d 2018 |d an international journal on biomedical and psychosocial approaches |g Amsterdam [u.a.] |w (DE-627)ELV000553670 |
773 | 1 | 8 | |g volume:132 |g year:2013 |g number:1 |g day:1 |g month:09 |g pages:387-390 |g extent:4 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.drugalcdep.2013.02.036 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OPC-PHA | ||
936 | b | k | |a 44.38 |j Pharmakologie |q VZ |
936 | b | k | |a 44.39 |j Toxikologie |q VZ |
951 | |a AR | ||
952 | |d 132 |j 2013 |e 1 |b 1 |c 0901 |h 387-390 |g 4 | ||
953 | |2 045F |a 610 |
author_variant |
w m c wm wmc |
---|---|
matchkey_str |
comptonwilsonmdawsondeborahagoldsteinris:2013----:rswlbtensidpnecads5usacueiodrfrpod |
hierarchy_sort_str |
2013 |
bklnumber |
44.38 44.39 |
publishDate |
2013 |
allfields |
10.1016/j.drugalcdep.2013.02.036 doi GBVA2013012000002.pica (DE-627)ELV016911024 (ELSEVIER)S0376-8716(13)00107-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Compton, Wilson M. verfasserin aut Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol 2013 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5. Substance use disorder Elsevier DSM-IV Elsevier DSM-5 Elsevier Kappa Elsevier Concordance Elsevier Diagnosis Elsevier Dawson, Deborah A. oth Goldstein, Risë B. oth Grant, Bridget F. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:132 year:2013 number:1 day:1 month:09 pages:387-390 extent:4 https://doi.org/10.1016/j.drugalcdep.2013.02.036 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 132 2013 1 1 0901 387-390 4 045F 610 |
spelling |
10.1016/j.drugalcdep.2013.02.036 doi GBVA2013012000002.pica (DE-627)ELV016911024 (ELSEVIER)S0376-8716(13)00107-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Compton, Wilson M. verfasserin aut Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol 2013 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5. Substance use disorder Elsevier DSM-IV Elsevier DSM-5 Elsevier Kappa Elsevier Concordance Elsevier Diagnosis Elsevier Dawson, Deborah A. oth Goldstein, Risë B. oth Grant, Bridget F. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:132 year:2013 number:1 day:1 month:09 pages:387-390 extent:4 https://doi.org/10.1016/j.drugalcdep.2013.02.036 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 132 2013 1 1 0901 387-390 4 045F 610 |
allfields_unstemmed |
10.1016/j.drugalcdep.2013.02.036 doi GBVA2013012000002.pica (DE-627)ELV016911024 (ELSEVIER)S0376-8716(13)00107-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Compton, Wilson M. verfasserin aut Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol 2013 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5. Substance use disorder Elsevier DSM-IV Elsevier DSM-5 Elsevier Kappa Elsevier Concordance Elsevier Diagnosis Elsevier Dawson, Deborah A. oth Goldstein, Risë B. oth Grant, Bridget F. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:132 year:2013 number:1 day:1 month:09 pages:387-390 extent:4 https://doi.org/10.1016/j.drugalcdep.2013.02.036 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 132 2013 1 1 0901 387-390 4 045F 610 |
allfieldsGer |
10.1016/j.drugalcdep.2013.02.036 doi GBVA2013012000002.pica (DE-627)ELV016911024 (ELSEVIER)S0376-8716(13)00107-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Compton, Wilson M. verfasserin aut Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol 2013 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5. Substance use disorder Elsevier DSM-IV Elsevier DSM-5 Elsevier Kappa Elsevier Concordance Elsevier Diagnosis Elsevier Dawson, Deborah A. oth Goldstein, Risë B. oth Grant, Bridget F. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:132 year:2013 number:1 day:1 month:09 pages:387-390 extent:4 https://doi.org/10.1016/j.drugalcdep.2013.02.036 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 132 2013 1 1 0901 387-390 4 045F 610 |
allfieldsSound |
10.1016/j.drugalcdep.2013.02.036 doi GBVA2013012000002.pica (DE-627)ELV016911024 (ELSEVIER)S0376-8716(13)00107-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Compton, Wilson M. verfasserin aut Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol 2013 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5. Substance use disorder Elsevier DSM-IV Elsevier DSM-5 Elsevier Kappa Elsevier Concordance Elsevier Diagnosis Elsevier Dawson, Deborah A. oth Goldstein, Risë B. oth Grant, Bridget F. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:132 year:2013 number:1 day:1 month:09 pages:387-390 extent:4 https://doi.org/10.1016/j.drugalcdep.2013.02.036 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 132 2013 1 1 0901 387-390 4 045F 610 |
language |
English |
source |
Enthalten in Statistical analysis to identify biomarkers for safety Amsterdam [u.a.] volume:132 year:2013 number:1 day:1 month:09 pages:387-390 extent:4 |
sourceStr |
Enthalten in Statistical analysis to identify biomarkers for safety Amsterdam [u.a.] volume:132 year:2013 number:1 day:1 month:09 pages:387-390 extent:4 |
format_phy_str_mv |
Article |
bklname |
Pharmakologie Toxikologie |
institution |
findex.gbv.de |
topic_facet |
Substance use disorder DSM-IV DSM-5 Kappa Concordance Diagnosis |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Statistical analysis to identify biomarkers for safety |
authorswithroles_txt_mv |
Compton, Wilson M. @@aut@@ Dawson, Deborah A. @@oth@@ Goldstein, Risë B. @@oth@@ Grant, Bridget F. @@oth@@ |
publishDateDaySort_date |
2013-01-01T00:00:00Z |
hierarchy_top_id |
ELV000553670 |
dewey-sort |
3610 |
id |
ELV016911024 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV016911024</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623132325.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drugalcdep.2013.02.036</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013012000002.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV016911024</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0376-8716(13)00107-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.39</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Compton, Wilson M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Substance use disorder</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DSM-IV</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DSM-5</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kappa</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Concordance</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diagnosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dawson, Deborah A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goldstein, Risë B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grant, Bridget F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Clark, Matthew ELSEVIER</subfield><subfield code="t">Statistical analysis to identify biomarkers for safety</subfield><subfield code="d">2018</subfield><subfield code="d">an international journal on biomedical and psychosocial approaches</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000553670</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:132</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1</subfield><subfield code="g">day:1</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:387-390</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drugalcdep.2013.02.036</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.38</subfield><subfield code="j">Pharmakologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.39</subfield><subfield code="j">Toxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">132</subfield><subfield code="j">2013</subfield><subfield code="e">1</subfield><subfield code="b">1</subfield><subfield code="c">0901</subfield><subfield code="h">387-390</subfield><subfield code="g">4</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Compton, Wilson M. |
spellingShingle |
Compton, Wilson M. ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Substance use disorder Elsevier DSM-IV Elsevier DSM-5 Elsevier Kappa Elsevier Concordance Elsevier Diagnosis Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol |
authorStr |
Compton, Wilson M. |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000553670 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol Substance use disorder Elsevier DSM-IV Elsevier DSM-5 Elsevier Kappa Elsevier Concordance Elsevier Diagnosis Elsevier |
topic |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Substance use disorder Elsevier DSM-IV Elsevier DSM-5 Elsevier Kappa Elsevier Concordance Elsevier Diagnosis |
topic_unstemmed |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Substance use disorder Elsevier DSM-IV Elsevier DSM-5 Elsevier Kappa Elsevier Concordance Elsevier Diagnosis |
topic_browse |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Substance use disorder Elsevier DSM-IV Elsevier DSM-5 Elsevier Kappa Elsevier Concordance Elsevier Diagnosis |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
d a d da dad r b g rb rbg b f g bf bfg |
hierarchy_parent_title |
Statistical analysis to identify biomarkers for safety |
hierarchy_parent_id |
ELV000553670 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
Statistical analysis to identify biomarkers for safety |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV000553670 |
title |
Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol |
ctrlnum |
(DE-627)ELV016911024 (ELSEVIER)S0376-8716(13)00107-5 |
title_full |
Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol |
author_sort |
Compton, Wilson M. |
journal |
Statistical analysis to identify biomarkers for safety |
journalStr |
Statistical analysis to identify biomarkers for safety |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2013 |
contenttype_str_mv |
zzz |
container_start_page |
387 |
author_browse |
Compton, Wilson M. |
container_volume |
132 |
physical |
4 |
class |
610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Compton, Wilson M. |
doi_str_mv |
10.1016/j.drugalcdep.2013.02.036 |
dewey-full |
610 |
title_sort |
crosswalk between dsm-iv dependence and dsm-5 substance use disorders for opioids, cannabis, cocaine and alcohol |
title_auth |
Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol |
abstract |
Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5. |
abstractGer |
Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5. |
abstract_unstemmed |
Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA |
container_issue |
1 |
title_short |
Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol |
url |
https://doi.org/10.1016/j.drugalcdep.2013.02.036 |
remote_bool |
true |
author2 |
Dawson, Deborah A. Goldstein, Risë B. Grant, Bridget F. |
author2Str |
Dawson, Deborah A. Goldstein, Risë B. Grant, Bridget F. |
ppnlink |
ELV000553670 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth |
doi_str |
10.1016/j.drugalcdep.2013.02.036 |
up_date |
2024-07-06T20:39:41.116Z |
_version_ |
1803863595278139392 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV016911024</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623132325.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drugalcdep.2013.02.036</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013012000002.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV016911024</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0376-8716(13)00107-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.39</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Compton, Wilson M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Substance use disorder</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DSM-IV</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DSM-5</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kappa</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Concordance</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diagnosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dawson, Deborah A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goldstein, Risë B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grant, Bridget F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Clark, Matthew ELSEVIER</subfield><subfield code="t">Statistical analysis to identify biomarkers for safety</subfield><subfield code="d">2018</subfield><subfield code="d">an international journal on biomedical and psychosocial approaches</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000553670</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:132</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1</subfield><subfield code="g">day:1</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:387-390</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drugalcdep.2013.02.036</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.38</subfield><subfield code="j">Pharmakologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.39</subfield><subfield code="j">Toxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">132</subfield><subfield code="j">2013</subfield><subfield code="e">1</subfield><subfield code="b">1</subfield><subfield code="c">0901</subfield><subfield code="h">387-390</subfield><subfield code="g">4</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.4003468 |